Rice Hall James Buys QuidelOrtho Stock

• The further shares accrued the QuidelOrtho involvement to 1.3% of the fund's 13F reportable assets nether absorption (AUM).

• Top holdings aft the filing:

  • NASDAQ: LGND: $52.8 cardinal (2.9% of AUM)

  • NYSE: ARLO: $50.0 cardinal (2.7% of AUM)

  • NASDAQ: FOLD: $49.9 cardinal (2.7% of AUM)

  • NYSE: FN: $48.4 cardinal (2.7% of AUM)

  • NASDAQ: ESTA: $47.4 cardinal (2.6% of AUM)

• As of Feb. 13, 2026, shares were priced astatine $23.58, down 43.4% implicit the past twelvemonth and trailing the S&P 500 by 55.2 percent points.

• Develops and manufactures diagnostic investigating technologies spanning labs, transfusion medicine, point-of-care, and molecular diagnostics, with a wide portfolio of objective chemistry, immunoassay, and humor screening products.

• Generates gross done nonstop income and distributor channels, offering instruments, consumables, and diagnostic tests for some nonrecreational and over-the-counter usage worldwide.

• Serves hospitals, objective and notation laboratories, doc offices, urgent attraction clinics, pharmacies, humor banks, donor centers, and retail clinics crossed North America, EMEA, China, and different planetary markets.

QuidelOrtho is simply a planetary supplier of diagnostic solutions, leveraging a diversified merchandise suite crossed halfway healthcare investigating segments. Its integrated concern exemplary combines proprietary technology, established distribution, and a wide lawsuit basal to thrust standard and recurring revenue. Strategic absorption connected innovation and planetary scope supports its competitory presumption successful the diagnostics industry.

Rice Hall James holds implicit 200 stocks and bought and sold respective positions successful the quarter, including importantly adding to its involvement successful QuidelOrtho.

The money seemingly sees the banal undervaluing the company’s prospects. QuidelOrtho is simply a person successful vitro diagnostics. It hasn’t delivered accordant gross maturation oregon profitability successful caller years, but worth investors whitethorn expect improving fiscal results with changes successful cardinal enactment positions past year.